The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
The American Academy of Neurology (AAN) has developed a new systematic review to summarize for neurologists and other clinicians the evidence for epidural steroid injections and whether they reduce ...
The FDA's sign-off on the medication comes as the agency says it is prioritizing supporting the development of non-opioid pain treatment. Suzetrigine is the first non-opioid analgesic – or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback